Literature DB >> 27287606

How to Avoid and Deal with Pelvic Mesh Litigation.

Matthew E Karlovsky1,2.   

Abstract

Medical malpractice as it relates to transvaginal mesh implantation adds another level of responsibility when deciding on surgical options to repair stress urinary incontinence or pelvic organ prolapse. As mesh is a viable option for repair, the informed consent process must involve a time commitment to discuss thoroughly the knowns and unknowns about mesh, and potentially must cover other aspects related to surgery: FDA classification of mesh, experience, potential off label usage, and conflicts of interest. A therapeutic alliance must be developed between physician and patient to allay possible fears about the intrinsic uncertainty of surgery. Proper risk assessment of the patient and pre-operative judgment as to when and if mesh implantation is appropriate are decisions that must be documented. Resolution of a conflict from a complication can be dealt with formally or informally. Above all, sharp skills, good communication, broad knowledge base of mesh surgeries, complication management, knowledge of guidelines, along with methodical documentation can mitigate or avert mesh-related litigation.

Entities:  

Keywords:  FDA bulletins; Informed consent; Litigation; Malpractice; Mesh complications; Standard of care

Mesh:

Year:  2016        PMID: 27287606     DOI: 10.1007/s11934-016-0613-3

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  9 in total

1.  Medical malpractice reform: the role of alternative dispute resolution.

Authors:  David H Sohn; B Sonny Bal
Journal:  Clin Orthop Relat Res       Date:  2012-05       Impact factor: 4.176

2.  An introduction to medical malpractice in the United States.

Authors:  B Sonny Bal
Journal:  Clin Orthop Relat Res       Date:  2008-11-26       Impact factor: 4.176

3.  The judgment defense in medical malpractice.

Authors:  B Sonny Bal; Lawrence H Brenner
Journal:  Clin Orthop Relat Res       Date:  2013-08-10       Impact factor: 4.176

4.  Corporate malfeasance, off-label use, and surgeon liability.

Authors:  B Sonny Bal; Lawrence H Brenner
Journal:  Clin Orthop Relat Res       Date:  2013-01       Impact factor: 4.176

5.  Medicolegal sidebar: corporate relationships and increased surgeon liability risk.

Authors:  B Sonny Bal; Lawrence H Brenner
Journal:  Clin Orthop Relat Res       Date:  2013-02-13       Impact factor: 4.176

6.  Ethical principles for introducing device and/or mesh use into your practice.

Authors:  Emily E Anderson
Journal:  Clin Obstet Gynecol       Date:  2013-06       Impact factor: 2.190

7.  What to disclose? Revisiting informed consent.

Authors:  B Sonny Bal; Theodore J Choma
Journal:  Clin Orthop Relat Res       Date:  2012-05       Impact factor: 4.176

Review 8.  Beyond informed consent: educating the patient.

Authors:  Lawrence H Brenner; Alison Tytell Brenner; Daniel Horowitz
Journal:  Clin Orthop Relat Res       Date:  2008-12-05       Impact factor: 4.176

9.  Apologies and medical error.

Authors:  Jennifer K Robbennolt
Journal:  Clin Orthop Relat Res       Date:  2008-10-30       Impact factor: 4.176

  9 in total
  2 in total

Review 1.  Prevention, diagnosis, and management of midurethral mesh sling complications.

Authors:  A Ross Hengel; Kevin V Carlson; Richard J Baverstock
Journal:  Can Urol Assoc J       Date:  2017-06       Impact factor: 1.862

2.  Effect of platelet-rich plasma on polypropylene meshes implanted in the rabbit vagina: histological analysis.

Authors:  Natália Gomes Parizzi; Oscar Ávila Rubini; Silvio Henrique Maia de Almeida; Lais Caetano Ireno; Roger Mitio Tashiro; Victor Hugo Tolotto de Carvalho
Journal:  Int Braz J Urol       Date:  2017 Jul-Aug       Impact factor: 1.541

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.